These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37247499)

  • 1. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile.
    Wang T; Guo K; Zhang D; Wang H; Yin J; Cui H; Wu W
    Int Immunopharmacol; 2023 Jul; 120():110368. PubMed ID: 37247499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC.
    Jia X; Wang Y; Yang Y; Fu Y; Liu Y
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study.
    Chen X; Liang Q; Zhou Y
    Medicine (Baltimore); 2023 Oct; 102(40):e35423. PubMed ID: 37800779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
    Yang L; Zhang W; Yan Y
    Aging (Albany NY); 2023 Jul; 15(13):6135-6151. PubMed ID: 37399661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration.
    Wei J; Wang J; Chen X; Zhang L; Peng M
    PeerJ; 2024; 12():e16819. PubMed ID: 38317842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma.
    Qu J; Guan H; Zheng Q; Sun F
    Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma.
    Zhao J; Luo Z; Fu R; Zhou J; Chen S; Wang J; Chen D; Xie X
    Eur J Med Res; 2023 Dec; 28(1):571. PubMed ID: 38057871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma.
    Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L
    Cancer Cell Int; 2024 Jan; 24(1):19. PubMed ID: 38195525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which
    Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X
    Front Immunol; 2023; 14():1205250. PubMed ID: 37426643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
    Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
    Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
    Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature.
    Tang C; Fan Y; Zhu S
    BMC Urol; 2024 Mar; 24(1):69. PubMed ID: 38532369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and experimental verification of a prognosis model for disulfidptosis-associated genes in HNSCC.
    Li Y; Tao L; Xin J; Dai Y; Chen X; Zou J; Wang R; Wang B; Liu Z
    Medicine (Baltimore); 2024 Mar; 103(12):e37308. PubMed ID: 38518012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma.
    Zhang H; Wang J; Yang M
    Medicine (Baltimore); 2024 Jan; 103(4):e36513. PubMed ID: 38277541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
    Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
    BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data.
    Wang Y; Yuan Z; Zhu Q; Ma J; Lu Q; Xiao Z
    J Gastrointest Oncol; 2024 Feb; 15(1):377-396. PubMed ID: 38482234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors.
    Huang J; Xu Z; Chen D; Zhou C; Shen Y
    Medicine (Baltimore); 2023 Dec; 102(52):e36830. PubMed ID: 38206694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.